RENAL CELL CARCINOMA

This adverse event was reported 4897 times

These drugs are most commonly taken by patients reporting RENAL CELL CARCINOMA:

# Drug Count
0 SUNITINIB MALATE 974
1 CABOZANTINIB 504
2 PAZOPANIB HYDROCHLORIDE 278
3 SORAFENIB 274
4 AXITINIB 244
5 OMEPRAZOLE MAGNESIUM 226
6 METHOTREXATE SODIUM 213
7 ASPIRIN 189
8 METHOTREXATE 189
9 PREDNISONE 181
See all common drugs associated with RENAL CELL CARCINOMA

RENAL CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEMSIROLIMUS 136 0.0302
1 SUNITINIB MALATE 974 0.0249
2 SORAFENIB 274 0.0132
3 AXITINIB 244 0.0125
4 CABOZANTINIB 504 0.0104
5 PAZOPANIB HYDROCHLORIDE 278 0.0103
6 BASILIXIMAB 63 0.0053
7 ERGOCALCIFEROL 122 0.0041
8 EVEROLIMUS TABLETS 64 0.0037
9 EVEROLIMUS 180 0.0036
See all drugs enriched for association with RENAL CELL CARCINOMA